No definition available.
Hypoplasia of dental enamel, prenatal , including avohilmo
K11_HYPOPLASIA_ENAMEL_PRENATAL_INCLAVO
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Hypoplasia of dental enamel, prenatal , including avohilmo
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3002 | 1580 | 1422 |
| Only index persons | 2001 | 1117 | 884 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.04 |
| Only index persons | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | - | 9.07 | 7.98 |
| Only index persons | 11.19 | 11.79 | 10.44 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 98 | 62 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 11.94 | 15.35 | 6.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 128
- Matched controls
- 1278
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
+∞
184.8
128
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
24.5
37.4
55
38
127
Kela drug reimbursment
Transplant complication
29.6
22.6
30
13
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
35.7
20.6
26
9
Z94.0
ICD-10 Finland
Kidney transplant status
35.7
20.6
26
9
H02AB04
ATC
methylprednisolone; systemic
15.3
18.6
31
26
H02AB09
ATC
hydrocortisone; systemic
12.8
17.2
31
31
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
14.1
16.8
29
26
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
35.4
16.7
21
7
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
29.1
16.7
22
9
L04AX01
ATC
azathioprine; systemic
13.5
16.5
29
27
ZX120
NOMESCO Finland
Intravenous
7.9
16.0
39
67
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.0
15.9
31
36
137
Kela drug reimbursment
Uraemia requiring dialysis
44.1
15.9
19
5
A11CC03
ATC
alfacalcidol; systemic
16.9
15.8
25
18
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
27.5
15.7
21
9
L04AA06
ATC
mycophenolic acid; systemic
19.7
15.5
23
14
SAA03
NOMESCO Finland
Extended examination of mouth
5.3
15.1
103
562
L04AD01
ATC
ciclosporin; systemic
18.7
14.6
22
14
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
48.6
14.5
17
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
29.6
13.8
18
7
TK800
NOMESCO Finland
Hemodialysis
29.6
13.8
18
7
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.9
13.7
28
35
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
45.2
13.5
16
*
A12AA04
ATC
calcium carbonate; oral
32.3
13.3
17
6
KAC00
NOMESCO Finland
Nephrectomy
25.8
13.3
18
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
13.2
42
101
ZXD05
NOMESCO Finland
Urgent procedure
4.4
12.7
58
204
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.1
12.7
24
26
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.7
12.4
24
27
K03.00
ICD-10 Finland
Approximal wear
12.4
12.3
22
21
Z99.2
ICD-10 Finland
Dependence on renal dialysis
51.9
12.1
14
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.8
12.1
32
60
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.4
12.1
25
32
B03XA01
ATC
erythropoietin; parenteral
25.8
11.9
16
7
C08CA01
ATC
amlodipine; oral
8.9
11.7
25
34
TK820
NOMESCO Finland
Peritoneal dialysis
38.9
11.5
14
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
38.9
11.5
14
*
Z2221
NOMESCO Finland
Medical doctor
3.9
11.4
63
255
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
7.7
11.4
27
43
ZXE20
NOMESCO Finland
More than three and less than five hours
4.9
11.1
40
109
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
11.0
55
203
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
12.2
10.7
19
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
10.6
65
284
B05DA
ATC
Isotonic solutions
35.8
10.5
13
*
1AB02
NOMESCO Finland
NA
21.0
10.5
15
8
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
14.9
10.5
17
13
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.1
10.4
35
88
TPH07
NOMESCO Finland
Cathetrisation of artery
4.8
10.2
37
100
Z49.2
ICD-10 Finland
Other dialysis
43.8
10.2
12
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
43.8
10.2
12
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
43.8
10.2
12
*
Z3226
NOMESCO Finland
Physiotherapist
3.6
10.0
60
253
R4110
NOMESCO Finland
Physiotherapy
3.6
10.0
60
254
Z2446
NOMESCO Finland
Social worker
3.7
9.9
52
198
4AA09
NOMESCO Finland
NA
32.8
9.6
12
*
I15.8
ICD-10 Finland
Other secondary hypertension
107.7
9.5
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
9.5
70
340
V03AE01
ATC
polystyrene sulfonate; oral
+∞
9.5
9
*
WX110
NOMESCO Finland
Local anesthesy
3.7
9.2
103
678
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
26.2
9.1
12
5
ZX199
NOMESCO Finland
Other rote
12.0
9.1
16
15
205
Kela drug reimbursment
Chronic hypertension
8.7
9.0
19
25
K06.18
ICD-10 Finland
Another gingival hyperplasia
15.5
8.9
14
10
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.7
8.7
31
82
5AB14
NOMESCO Finland
NA
21.9
8.6
12
6
L04AA01
ATC
[U] ciclosporin; systemic
29.8
8.6
11
*
RD210
NOMESCO Finland
NA
5.1
8.6
28
67
3A013
NOMESCO Finland
NA
96.1
8.5
9
*
783
NOMESCO Finland
NA
+∞
8.4
8
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
15.9
8.4
13
9
602
Kela drug reimbursment
Children's severe malnutrition
6.3
8.3
22
41
K03.66
ICD-10 Finland
Tooth plaque
3.7
8.3
41
146
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
8.3
40
140
SFA10
NOMESCO Finland
Fillning on one surface of tooth
3.0
8.2
81
464
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.3
8.1
25
56
SFA40
NOMESCO Finland
Replacement of krone of tooth
6.8
8.1
20
34
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.3
8.0
17
23
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
7.9
41
150
K00.50
ICD-10 Finland
Dentinal dysplasia
16.4
7.9
12
8
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
7.8
39
139
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.3
7.8
30
85
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
19.9
7.7
11
6
WW500
NOMESCO Finland
Blood transfusion
7.3
7.7
18
28
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
7.6
58
276
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
4.2
7.6
30
87
Z2445
NOMESCO Finland
Psychologist
3.7
7.6
36
123
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.0
7.5
24
56
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.4
7.5
40
150
SCE00
NOMESCO Finland
Fissure closure of tooth
3.4
7.4
42
162
K02.0
ICD-10 Finland
Caries limited to enamel
2.9
7.1
54
258
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.6
7.0
20
41
RS121
NOMESCO Finland
NA
9.1
7.0
14
17
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.7
7.0
77
456
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
11.9
7.0
12
11
IEP02
NOMESCO Finland
Child-centred family therapy
5.4
6.9
20
42
A41.9
ICD-10 Finland
Sepsis, unspecified
8.6
6.8
14
18
K02.1
ICD-10 Finland
Caries of dentine
2.7
6.7
84
532
WX882
NOMESCO Finland
High dependency care
3.2
6.6
39
155
ZXE00
NOMESCO Finland
One hour or less
2.7
6.6
76
454
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.2
6.6
17
31
Z01.2
ICD-10 Finland
Dental examination
2.7
6.4
89
588
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
6.4
52
253
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
28.2
6.3
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
6.0
67
388
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
25
12
24.51
33.59
8.0
6.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
25
12
24.51
33.59
8.0
6.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
27
18
17.84
31.26
60.8
46.6
ug/l
6.1
6.8
0.92
27
18
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
15
19.57
30.42
11.7
12.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
35
40
10.92
29.20
19.3
13.2
iu/ml
1670.2
213.8
—
5
10
(40768446) Kidney Pathology biopsy report
24
18
15.51
25.96
3.2
2.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
39
70
7.04
22.10
4.9
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
72
6.84
21.48
4.9
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
38
8.72
20.19
2.8
1.7
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
7
39.94
19.53
8.8
10.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
40
84
6.02
19.23
4.2
2.2
u/ml
187.3
122.6
0.85
23
38
(3020393) Adenovirus Ag [Presence] in Stool
29
44
7.83
19.01
2.7
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
86
5.87
18.73
4.2
2.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
21
22
10.84
18.29
5.3
4.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
59
197
4.16
15.93
44.9
11.4
mmol/l
0.8
0.8
4.63
59
182
(4035726)
31
61
6.06
15.79
2.2
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
12
13.69
15.35
3.1
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
41
7.04
15.17
2.8
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
36
7.29
14.53
23.0
12.3
u/ml
0.3
0.3
0.81
18
23
(3051651) Icteric interference index of Serum or Plasma
20
29
7.74
13.47
5.0
4.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
58
5.64
13.43
3.4
2.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
31
7.23
12.69
5.0
4.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
46
5.96
12.45
2.2
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
42
132
3.96
12.01
6.5
5.6
e9/l
58.2
63.2
0.45
36
88
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
56
5.35
11.90
3.1
2.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
52
191
3.55
11.81
10.1
7.5
%
1.5
1.4
0.41
52
181
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
151
3.75
11.69
4.1
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
278
3.25
11.51
7.5
3.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
43
5.77
11.15
2.7
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
42
5.60
10.37
2.4
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
70
329
3.00
10.33
8.3
3.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
59
4.84
10.27
5.5
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
119
3.74
10.13
2.8
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
25
62
4.59
9.66
8.3
4.5
%
0.0
0.7
1.35
15
14
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
19
38
5.54
9.35
8.5
4.5
%
100.5
98.3
0.12
19
38
(3000991) Gas panel - Venous blood
66
314
2.88
9.35
31.4
11.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
27
6.47
9.32
2.8
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
51
212
3.06
9.21
8.9
4.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
16
28
6.24
8.99
1.4
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
29
6.02
8.69
3.6
4.3
umol/l
22.0
27.7
0.81
16
29
(3017181) Myelocytes/100 leukocytes in Blood
25
68
4.17
8.56
9.0
5.7
%
0.2
0.6
0.81
18
23
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
26
6.26
8.50
1.5
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
169
3.11
8.48
19.2
8.2
umol/l
5.0
5.4
0.14
35
136
(3000494) Fungus identified in Specimen by Culture
31
100
3.60
8.37
2.0
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
23
61
4.24
8.13
9.3
6.0
%
0.0
0.0
0.00
18
20
(3025159) Blasts/100 leukocytes in Blood
23
61
4.24
8.13
8.5
6.0
%
0.0
0.0
0.00
15
17
(3004119) Hemoglobin [Mass/volume] in Venous blood
24
66
4.10
8.09
41.1
15.0
g/l
119.7
125.5
0.56
24
66
(3002032) Base excess in Venous blood by calculation
67
342
2.65
8.06
41.9
10.3
mmol/l
1.0
0.8
0.35
60
254
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
82
468
2.54
7.76
11.6
3.6
nmol/l
83.5
70.4
4.46
82
446
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
54
4.33
7.71
2.3
2.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
66
344
2.56
7.51
43.0
10.2
kpa
5.5
5.7
1.05
66
333
(3033658) Prothrombin time (PT) actual/Normal
66
344
2.56
7.51
20.8
8.8
%
84.3
85.9
0.22
66
339
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
161
2.98
7.50
3.7
2.1
—
—
—
0
0
(44806118)
20
51
4.34
7.41
3.4
2.4
—
—
—
0
0
(44790048)
20
51
4.34
7.41
3.4
2.4
—
—
—
0
0
(44790049)
20
51
4.34
7.41
3.4
2.4
—
—
—
0
0
(44790047)
20
51
4.34
7.41
3.4
2.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
27
88
3.49
7.14
2.5
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
52
249
2.61
6.97
13.8
4.6
inr
1.1
1.1
—
8
65
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
24
5.81
6.89
2.1
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
133
2.98
6.66
3.8
2.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
13
25
5.57
6.61
2.8
2.8
mmol/l
30.3
32.0
0.07
13
25
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
134
2.95
6.57
3.4
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
62
332
2.42
6.49
41.0
10.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
62
333
2.41
6.44
41.7
10.1
kpa
5.4
5.3
0.28
62
322
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
73
422
2.34
6.40
18.8
9.5
umol/l
25.3
28.6
0.20
68
391
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
15
7.04
6.39
1.0
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
15
7.04
6.39
23.6
5.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
34
4.76
6.38
14.7
10.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
43
4.30
6.35
4.8
3.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
26
5.35
6.34
1.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
458
2.26
5.93
8.5
4.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
82
510
2.25
5.93
25.7
10.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
24
5.32
5.84
18.5
4.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
92
613
2.18
5.45
7.9
3.3
ug/l
60.0
59.6
0.01
87
578
(3000060) B lymphocytes [#/volume] in Blood
19
59
3.52
5.37
5.6
4.2
e6/l
162.9
516.0
3.31
14
43
(3030467) Casts [#/volume] in Urine by Automated count
71
431
2.16
5.30
17.6
4.2
e6/l
0.1
0.2
0.41
61
324
(3025941) Bacteria identified in Stool by Culture
16
45
3.84
5.19
1.7
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
71
434
2.14
5.18
17.0
4.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
36
4.17
5.10
39.5
21.1
%
75.1
75.9
0.08
14
36
(42870588) Differential panel, method unspecified - Blood
95
654
2.11
5.02
29.0
10.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
68
3.22
4.92
2.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
68
3.22
4.92
2.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
375
2.12
4.87
44.2
10.4
mmol/l
0.9
1.2
0.52
55
263
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
495
2.07
4.84
18.3
4.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
7
11.94
4.84
3.0
1.7
pg
30.0
34.0
—
8
7
(3009343) pH of Capillary blood
63
376
2.11
4.82
44.4
10.4
ph
7.4
7.4
—
5
6
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
58
3.37
4.81
5.9
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
344
2.13
4.80
8.5
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
97
687
2.05
4.59
16.7
5.0
u/l
161.2
132.7
1.66
92
647
(3013115) Eosinophils [#/volume] in Blood
113
851
2.12
4.46
34.1
11.0
e9/l
0.3
0.2
0.37
107
717
(40768804) Tissue Pathology biopsy report
47
259
2.15
4.36
2.0
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
9
9.28
4.33
2.0
2.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
36
3.84
4.30
41.9
22.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
286
2.09
4.20
11.8
3.9
e6/l
0.9
0.5
0.35
38
175
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
42
3.56
4.15
3.9
5.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
44
241
2.14
4.12
14.6
3.5
ph
7.4
7.4
—
7
34
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
10
8.35
4.11
2.4
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
113
865
2.04
4.08
29.2
9.7
e9/l
2.5
2.6
0.29
108
737
(3006315) Basophils [#/volume] in Blood
110
835
2.02
4.06
29.7
9.8
e9/l
0.0
0.0
1.37
103
682
(3001604) Monocytes [#/volume] in Blood
110
835
2.02
4.06
29.6
9.8
e9/l
0.6
0.6
0.01
103
683
(3013650) Neutrophils [#/volume] in Blood by Automated count
116
900
2.05
3.99
34.9
11.7
e9/l
3.2
3.6
1.57
107
740
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
44
3.39
3.88
32.5
5.0
%
44.4
62.9
1.70
14
44
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
29
4.00
3.87
2.2
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
29
4.00
3.87
46.3
25.7
%
11.6
12.2
0.26
11
29
(3010015) Selenium [Moles/volume] in Serum or Plasma
9
15
6.29
3.87
2.4
2.6
umol/l
1.0
1.0
—
9
15
(3007853) Bacteria identified in Skin by Aerobe culture
35
180
2.21
3.82
3.7
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
62
395
1.93
3.79
55.6
13.6
mmol/l
24.2
24.5
0.26
62
395
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
45
3.31
3.75
3.7
2.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
16
5.89
3.71
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
9
8.07
3.59
4.9
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
70
471
1.86
3.58
19.6
4.2
e6/l
72.6
29.5
0.48
60
362
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
49
293
1.97
3.58
14.1
4.0
e6/l
2.5
1.8
0.19
38
183
(3022145) Colonoscopy Study observation
15
52
3.08
3.57
1.8
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
37
200
2.11
3.55
2.1
1.9
mmol/l
1.1
1.3
0.37
37
184
(3026008) Bacteria identified in Urine by Culture
51
310
1.95
3.55
5.3
2.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
78
545
1.84
3.53
23.2
5.1
e6/l
16.6
44.5
1.38
61
371
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
14
5.95
3.38
1.8
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
97
2.47
3.38
2.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
33
3.51
3.25
1.3
1.2
—
—
—
0
0
(3013512) EKG study
26
126
2.27
3.25
2.8
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
15
5.55
3.23
2.4
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
20
4.70
3.16
1.1
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
8
7.73
3.08
8.8
6.6
ug/l
315.3
242.0
—
6
8
(3008037) Lactate [Moles/volume] in Venous blood
7
12
6.04
3.05
24.6
1.8
mmol/l
1.1
1.1
—
7
12
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
46
2.99
3.00
11.1
20.7
—
—
—
0
0
(4306422)
8
17
4.89
2.96
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
9
22
4.27
2.93
5.4
9.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
13
5.58
2.90
1.4
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
9
6.87
2.89
1.3
1.7
umol/l
23.2
18.9
—
6
9
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
9
6.87
2.89
1.2
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
18
4.62
2.83
1.1
1.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
6
8.55
2.77
1.4
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
14
5.17
2.76
1.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
15
4.83
2.62
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
44
2.87
2.61
2.1
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
8
20
4.15
2.60
24.5
4.0
kpa
11.0
9.2
—
8
20
(3013290) Carbon dioxide [Partial pressure] in Blood
8
20
4.15
2.60
24.5
4.0
kpa
4.8
4.6
—
8
20
(40760892) CBC W Ordered Manual Differential panel - Blood
40
247
1.83
2.58
14.9
4.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
11
5.62
2.56
2.5
1.5
u/ml
2335.3
1301.9
—
6
11
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
7
7.32
2.56
2.4
7.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
57
2.60
2.52
2.1
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
45
2.80
2.51
1.4
3.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
21
3.95
2.50
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
8
6.41
2.39
1.2
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
8
6.41
2.39
1.2
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
8
6.41
2.39
1.0
1.8
umol/l
8.8
8.5
—
5
8
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
17
4.25
2.39
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
11
41
2.81
2.33
14.1
3.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
47
2.68
2.33
1.2
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
8
23
3.60
2.30
9.1
2.1
mmol/l
1.6
1.8
—
8
23
(3024932) HLA-DR beta [Type]
7
18
4.02
2.28
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
18
4.02
2.28
1.0
1.0
—
—
—
0
0
(3015736) pH of Urine
62
448
1.63
2.25
9.2
3.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
9
5.69
2.23
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
9
5.69
2.23
29.0
1.9
mmol/l
5.2
5.5
—
5
9
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
19
3.80
2.17
1.4
2.8
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
14
4.41
2.17
1.0
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
398
1.63
2.15
1.9
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
145
0.32
2.15
2.4
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
144
0.33
2.15
2.4
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
144
0.33
2.15
2.4
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
62
2.38
2.14
1.4
1.3
g/l
0.2
0.2
0.05
14
57
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
10
5.12
2.08
1.2
1.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
5
10
5.12
2.08
1.0
1.2
%
87.8
86.7
—
5
10
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
14
63
2.34
2.07
1.4
1.3
g/l
1.1
1.2
0.62
14
57
(3028433) Virus identified in Specimen by Culture
6
15
4.11
2.06
1.7
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
214
1.75
2.04
1.8
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
57
2.39
2.03
1.5
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
12
51
2.46
2.00
11.8
19.8
%
95.0
94.9
0.02
12
51
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
51
2.46
2.00
11.8
19.7
%
1.0
0.9
0.17
12
51
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
51
2.46
2.00
11.8
19.7
%
0.7
0.7
0.03
12
51
(3027944) Amphetamines [Presence] in Urine
5
142
0.33
2.00
2.4
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
21
3.44
1.99
1.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
27
3.06
1.96
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
11
4.65
1.95
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
116
1.93
1.89
1.4
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
28
2.95
1.89
1.9
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
73
2.16
1.87
2.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
99
821
1.54
1.87
39.5
11.7
e9/l
0.0
0.0
0.50
83
618
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
12
4.26
1.83
1.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
12
4.26
1.83
1.2
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
12
4.26
1.83
1.2
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
23
3.13
1.82
1.4
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
74
581
1.51
1.78
12.1
3.4
estimate
0.0
0.0
0.00
15
100
(3021601) Nitrite [Presence] in Urine by Test strip
74
582
1.51
1.76
18.2
5.1
estimate
0.0
0.0
0.00
17
104
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
48
2.39
1.75
4.5
3.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
24
3.00
1.74
1.3
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
24
3.00
1.74
3.9
5.9
ug/l
26.7
24.8
—
7
24
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
13
3.93
1.73
1.0
1.9
%
144.6
105.1
—
5
13
(4268621)
5
13
3.93
1.73
2.2
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
130
0.36
1.72
2.4
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
74
586
1.49
1.68
12.1
3.5
estimate
0.0
0.0
0.00
17
103
(3037467) Urinalysis macro (dipstick) panel - Urine
99
832
1.50
1.67
16.7
4.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
25
2.88
1.67
1.3
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
32
2.58
1.62
2.8
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
20
3.08
1.59
2.0
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
116
1.83
1.57
2.5
2.5
u/l
5.1
5.5
—
10
68
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
12
58
2.16
1.53
11.8
17.1
mmol/l
23.2
24.2
1.01
12
58
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
15
3.40
1.53
1.0
1.8
%
151.6
94.0
—
5
15
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
102
1.86
1.52
2.6
2.6
iu/l
15.8
8.9
—
10
63
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
21
2.93
1.52
9.0
2.7
e9/l
3.0
3.0
—
6
21
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
39
2.38
1.45
1.8
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
16
3.19
1.45
2.4
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
22
2.79
1.45
9.8
2.8
%
43.8
49.5
—
6
22
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
46
2.25
1.43
4.9
6.3
ug/l
3.2
2.4
—
10
46
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
23
2.67
1.38
1.3
4.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
23
2.67
1.38
1.3
4.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
43
316
1.49
1.37
1.8
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
47
2.20
1.37
25.9
3.0
mmol/l
1.2
1.2
—
10
39
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
42
2.21
1.36
1.8
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
24
2.56
1.31
3.2
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
24
156
1.63
1.29
2.0
1.5
titre
240.0
761.6
—
5
25
(42529406) Shigella sp [Presence] in Stool by Culture
9
44
2.11
1.29
1.8
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
35
2.35
1.29
4.8
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
56
439
1.42
1.28
2.1
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
141
1308
1.66
1.25
41.6
11.0
mg/l
21.1
22.6
0.29
107
951
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
32
226
1.52
1.23
2.1
1.5
pmol/l
91.2
93.5
0.13
14
115
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
85
727
1.36
1.12
3.4
2.3
mmol/l
5.2
5.3
1.13
79
661
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
8
41
2.00
1.10
1.0
1.0
g/l
173.1
162.7
—
8
41
(3007164) IgA [Mass/volume] in Serum or Plasma
71
592
1.36
1.10
2.7
1.7
g/l
1.5
1.4
0.35
48
276
(3014051) Protein [Presence] in Urine by Test strip
5
21
2.42
1.10
3.8
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
32
2.24
1.09
1.3
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
32
2.24
1.09
1.3
1.2
%
73.7
80.5
—
7
32
(4062490)
7
32
2.24
1.09
1.1
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
125
1145
1.42
1.03
63.9
13.8
mmol/l
4.1
4.0
1.71
117
1110
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
61
1.86
1.01
3.1
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
37
1.93
0.95
3.3
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
9
154
0.56
0.94
1.1
1.3
u/ml
0.6
0.9
—
9
118
(3003888) Timothy IgE Ab [Units/volume] in Serum
9
154
0.56
0.94
1.1
1.3
u/ml
2.3
5.8
—
9
122
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
434
1.33
0.90
1.9
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
65
1.74
0.84
5.5
5.8
—
—
—
0
0
(4198724)
0
24
0.00
0.80
0.0
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
144
1371
1.50
0.78
56.4
16.0
%
36.7
38.5
3.49
129
1253
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
54
1.71
0.76
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
106
0.55
0.75
1.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
92
1.57
0.75
2.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
60
1.71
0.74
6.2
6.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
60
1.71
0.74
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
25
2.03
0.73
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
26
1.95
0.71
2.0
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
26
1.95
0.71
1.6
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
61
1.68
0.70
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
27
1.88
0.69
2.4
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.88
0.69
1.6
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
137
1301
1.37
0.67
28.9
8.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
20
0.00
0.61
0.0
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000492) Spirometry study
12
81
1.52
0.59
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
35
290
1.26
0.54
12.0
3.4
estimate
0.0
0.0
0.00
15
103
(3016018) Differential panel - Cerebral spinal fluid
6
40
1.52
0.52
5.8
5.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
76
1.48
0.49
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
33
276
1.25
0.47
11.2
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
48
1.48
0.47
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
49
1.45
0.46
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
283
0.78
0.46
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18
139
1.33
0.46
1.8
2.6
ng/l
41.8
20.8
—
6
51
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
32
1.58
0.42
1.6
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
33
1.53
0.41
1.8
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
33
1.53
0.41
2.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
59
1.37
0.41
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
15
0.00
0.41
0.0
1.1
—
158.0
—
0
15
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
35
1.44
0.39
1.4
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
66
1.39
0.39
1.4
1.5
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
12
89
1.38
0.39
1.0
1.0
mmol/l
20.1
19.4
0.36
12
89
(40761536) Microorganisms panel - Urine sediment
12
89
1.38
0.39
14.6
3.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
12
90
1.36
0.37
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
67
614
1.16
0.36
14.8
6.3
ml/min/173m2
104.4
108.4
0.41
39
416
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
183
1.23
0.34
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
46
1.32
0.33
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
46
1.32
0.33
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
12
92
1.33
0.33
1.5
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
52
1.36
0.31
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
62
1.31
0.28
2.8
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
122
1.25
0.28
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
95
1.28
0.27
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
140
1366
1.20
0.27
4.6
4.2
—
—
—
0
0
(4010399)
9
75
1.21
0.25
2.0
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
106
1.25
0.24
1.1
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
40
1.26
0.22
1.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
48
1.26
0.20
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
86
0.81
0.15
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
85
0.82
0.15
2.9
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
160
1.14
0.14
1.8
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
41
387
1.08
0.12
10.6
3.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
147
0.87
0.12
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
125
0.87
0.10
1.2
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
45
1.11
0.10
2.0
3.0
nmol/l
4.9
0.4
—
5
40
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
599
1.06
0.09
1.8
1.8
u/ml
3.0
5.0
—
9
80
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
58
1.04
0.08
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
58
1.04
0.08
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
58
1.04
0.08
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
58
1.04
0.08
1.5
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
63
1.12
0.08
4.6
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
132
0.90
0.07
2.3
1.4
%
1.7
1.4
0.36
12
122
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12
130
0.92
0.05
1.2
1.2
u/ml
1.3
6.8
—
5
45
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
97
957
1.03
0.04
3.7
3.4
pmol/l
14.2
14.5
0.52
87
878
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
111
1.09
0.04
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
329
1.04
0.04
2.4
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
47
461
1.03
0.02
3.3
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
108
1071
1.03
0.02
5.5
3.7
mu/l
2.3
2.0
1.55
102
1009
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
103
1.07
0.02
1.7
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
34
348
0.97
0.02
2.7
2.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
67
678
0.98
0.01
2.1
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
247
0.97
0.01
2.6
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
263
1.03
0.01
1.4
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
204
1.03
0.00
2.1
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
206
0.97
0.00
2.4
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
137
1.02
0.00
1.4
1.2
iu/ml
10.4
11.4
—
6
34
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
64
0.94
0.00
1.3
1.4
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
0.5
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
22.8
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
6.5
—
0
5
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
86.3
—
0
5
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_HYPOPLASIA_ENAMEL_PRENATAL_INCLAVO and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_HYPOPLASIA_ENAMEL_PRENATAL_INCLAVO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_HYPOPLASIA_ENAMEL_PRENATAL_INCLAVO – Hypoplasia of dental enamel, prenatal , including avohilmo
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data